Jason A Keyes Equillium, Inc. (EQ) insider trading activity

Jason A Keyes is Chief Financial Officer of Equillium, Inc.. Currently has a direct ownership of 88,913 shares of EQ, which is worth approximately $60,460. The most recent transaction as insider was on Dec 10, 2024, when has been sold 15,000 shares (Common Stock) at a price of $0.54 per share, resulting in proceeds of $8,100. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 88.9K

50.92% 3M change

50.92% 12M change

Total Value Held $60,460

Jason A Keyes Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 10 2024	BUY Grant, award, or other acquisition	$8,100 $0.54 p/Share	15,000 Added 14.44%	88,913 Common Stock
Dec 08 2023	BUY Grant, award, or other acquisition	$5,106 $0.58 p/Share	8,805 Added 13.0%	58,913 Common Stock
Jun 09 2023	BUY Grant, award, or other acquisition	$8,400 $0.56 p/Share	15,000 Added 23.04%	50,108 Common Stock
Dec 09 2022	BUY Grant, award, or other acquisition	$5,288 $1.19 p/Share	4,444 Added 11.24%	35,108 Common Stock
Dec 10 2021	BUY Grant, award, or other acquisition	$13,125 $2.35 p/Share	5,585 Added 19.34%	23,296 Common Stock
Jun 10 2021	BUY Grant, award, or other acquisition	$13,007 $2.35 p/Share	5,535 Added 23.81%	17,711 Common Stock, par valu...
Dec 10 2020	BUY Other acquisition or disposition	$12,601 $2.35 p/Share	5,362 Added 30.57%	12,176 Common Stock

Also insider at

SESN

Sesen Bio, Inc. Healthcare

Director

ACTU

ACTUATE THERAPEUTICS, INC.

Director

JAK

Jason A Keyes

Chief Financial Officer

La Jolla, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EQ shares.

Notify only if

Value

Insider Trading

Get notified when an Equillium, Inc. insider buys or sells EQ shares.

Notify only if

Operation

Value

Type

News

Receive news related to Equillium, Inc.

Track Activities on EQ

Account